Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

15.62 -0.40 (-2.50%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,824
Open 15.68
Bid (Size) 15.59 (500)
Ask (Size) 15.76 (200)
Prev. Close 16.02
Today's Range 15.62 - 15.78
52wk Range 8.510 - 26.18
Shares Outstanding 55,096,537
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
From DBV Technologies S.A.
Via GlobeNewswire

Performance

YTD
-18.0%
-18.0%
1 Month
-14.0%
-14.0%
3 Month
-22.7%
-22.7%
6 Month
-18.5%
-18.5%
1 Year
+80.8%
+80.8%

More News

Read More
News headline image
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces the Results of its 2026 Combined General Meeting
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Combined General Meeting of June 3, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Reports First Quarter 2026 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in Upcoming March Investor Conferences
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
Via MarketMinute
Topics Intellectual Property
News headline image
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
News headline image
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
From DBV Technologies S.A.
Via GlobeNewswire

Frequently Asked Questions

Is DBV Technologies S.A. - American Depositary Shares publicly traded?
Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.
What exchange does DBV Technologies S.A. - American Depositary Shares trade on?
DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?
The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market
What is the current price of DBV Technologies S.A. - American Depositary Shares?
The current price of DBV Technologies S.A. - American Depositary Shares is 15.62
When was DBV Technologies S.A. - American Depositary Shares last traded?
The last trade of DBV Technologies S.A. - American Depositary Shares was at 06/26/26 09:30 AM ET
What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?
The market capitalization of DBV Technologies S.A. - American Depositary Shares is 860.61M
How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?
DBV Technologies S.A. - American Depositary Shares has 861M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.